DLEU2L and pachyonychia congenita: Therefore, over-expressed DLEU2L targeted miR-210-3p, reduced its biological activity and simultaneously upregulated intracellular BRCA2 level, mTOR phosphorylation was inhibited, thus decreasing the potential chemotherapy resistance of gemcitabine in PC treatment and enhancing its cytotoxic effect.